Hepatobiliary and pancreatic: Multi‐donor fecal microbiota transplantation attenuated high‐fat diet‐induced hepatic steatosis in mice by remodeling the gut microbiota

NAFLD patients and healthy controls showed distinct gut microbiota. Likewise, HFD altered gut microbiota in mice compared to NCD-fed controls. MD-FMT restored gut dysbiosis in HFD-fed mice and attenuated liver steatosis, and should be considered as an effective treatment option for NAFLD.